Research Activity
T-cell dysfunction as a potential contributing factor in postCOVID-19 mucormycosi
Start at : November 10, 2022
Published In Mycoses
The second wave of COVID-19 in India was followed by large number of mucormycosis cases. Indiscriminate use of immunosuppressive drugs, and underlying diseases such as diabetes, cancers, or autoimmune diseases was thought to be the cause. However, the mortality was not as high as that seen in non-COVID mucormycosis.